Naiyer Rizvi, MD Price Family Professor of Medicine and Director of Thoracic Oncology, Co-Director of Cancer Immunotherapy, Columbia Irving Medical Center addresses on the future of non-small cell lung cancer (NSCLC) drug development.
Drug Development for NSCLC
